Newsstand

Major world news, compressed into useful 100-word briefs with source attribution.

Updated every 30 minutes

I’m 71 and still working. I earn $108,000 a year. Am I doing the right thing?

MarketWatch//100-word brief
The short version

I’m 71 and still working. I earn $108,000 a year. Am I doing the right thing. “I have $152,000 in my IRA and Roth accounts.”.

Source attribution

This Newsstand page summarizes and points to reporting from MarketWatch. The original publisher owns the full story, reporting, quotes, images, and any later updates.

Visit original source

Related briefs

Healthline/1m ago

Microdosing GLP-1s Like Wegovy, Zepbound May Still Lead to Weight Loss

Microdosing GLP-1s Like Wegovy, Zepbound May Still Lead to Weight Loss. Research shows that microdosing GLP-1 medications may still lead to weight loss. Tatsiana Volkava · Moment/Getty Recent research suggests that people may still lose weight while staying on the lowest starting doses of GLP-1 medications, such as Wegovy or Zepbound, for longer periods. After one year, people taking sustained low dose tirzepatide lost about 5.5% of their body weight, while those taking sustained low dose semaglutide lost about 2.2%. Lower doses were associated with more modest weight loss than higher doses, but sustained low dose semaglutide was also associated.

I’m 71 and still working. I earn $108,000 a year.. | MarketWatch Brief | Newsstand